Reduced muscle necrosis and long-term benefits in dystrophic mdx mice after cV1q (blockade of TNF) treatment

Neuromuscular Disorders : NMD
Hannah G RadleyM D Grounds

Abstract

Tumour necrosis factor (TNF) is a potent inflammatory cytokine that appears to exacerbate damage of dystrophic muscle in vivo. The monoclonal murine specific antibody cV1q that specifically neutralises murine TNF demonstrated significant anti-inflammatory effects in dystrophic mdx mice. cV1q administration protected dystrophic skeletal myofibres against necrosis in both young and adult mdx mice and in adult mdx mice subjected to 48 h voluntary wheel exercise. Long-term studies (up to 90 days) in voluntarily exercised mdx mice showed beneficial effects of cV1q treatment with reduced histological evidence of myofibre damage and a striking decrease in serum creatine kinase levels. However, in the absence of exercise long-term cV1q treatment did not reduce necrosis or background pathology in mdx mice. An additional measure of well-being in the cV1q treated mice was that they ran significantly more than control mdx mice.

References

Jan 1, 1988·Neuropathology and Applied Neurobiology·G R CoultonJ C Sloper
Feb 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·G BulfieldK J Moore
Nov 1, 1993·Journal of the Neurological Sciences·J K McGeachieJ E Morgan
Apr 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·B J PetrofH L Sweeney
Feb 3, 1998·Neuromuscular Disorders : NMD·V BrusseeJ P Tremblay
Jun 6, 2000·Neuromuscular Disorders : NMD·J A GranchelliM S Hudecki
Oct 19, 2000·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·J D WhiteM D Grounds
Feb 13, 2001·Clinical Immunology : the Official Journal of the Clinical Immunology Society·M J SpencerJ G Tidball
Aug 30, 2001·Neuromuscular Disorders : NMD·M J Spencer, J G Tidball
Oct 3, 2001·The Journal of Cell Biology·M WehlingJ G Tidball
Mar 28, 2002·Physiological Reviews·Derek J BlakeKay E Davies
May 21, 2003·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·E V Cheung, J G Tidball
Oct 14, 2004·Laboratory Animals·I S McLennan, J Taylor-Jeffs
Feb 1, 2005·The American Journal of Pathology·Annamaria De LucaDiana Conte Camerino
Jul 30, 2005·Neuromuscular Disorders : NMD·Patrick Reed, Robert J Bloch
Feb 9, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jonathan D ArcherJudy E Anderson
Jun 27, 2006·Neurobiology of Disease·Hannah G Radley, Miranda D Grounds
Dec 22, 2006·Proceedings of the National Academy of Sciences of the United States of America·Silvia BrunelliEmilio Clementi
Feb 1, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Mario PescatoriEnzo Ricci
May 12, 2007·Cytokine & Growth Factor Reviews·Ian A Clark
May 16, 2007·Muscle & Nerve·Julie E HallMark A Tarnopolsky
Jun 15, 2007·Free Radical Biology & Medicine·Jan J KaczorMark A Tarnopolsky

❮ Previous
Next ❯

Citations

Mar 7, 2009·Nature Medicine·James G Tidball, S Armando Villalta
Jan 25, 2008·Clinical and Experimental Pharmacology & Physiology·Miranda D GroundsThea Shavlakadze
May 20, 2009·The Journal of Clinical Investigation·Sylvia A VetroneMelissa J Spencer
Sep 8, 2010·BMC Musculoskeletal Disorders·David J NyeJeffrey H Plochocki
Jul 30, 2011·Skeletal Muscle·Christopher J MannPura Muñoz-Cánoves
Nov 19, 2011·PLoS Currents·Hannah G Radley-CrabbMiranda D Grounds
Jun 16, 2012·International Journal of Biological Sciences·Susan Tsivitse Arthur, Ian D Cooley
Oct 3, 2013·Human Molecular Genetics·Colleen E D'ArcyMeagan J McGrath
Feb 18, 2011·Expert Opinion on Emerging Drugs·Stefan M Gehrig, Gordon S Lynch
Feb 18, 2011·Experimental and Molecular Pathology·Hiroshi NemotoToshiki Fujioka
Oct 21, 2015·Rare Diseases·S Armando VillaltaJeffrey A Bluestone
Jun 24, 2010·Experimental Cell Research·Antonio L Serrano, Pura Muñoz-Cánoves
Mar 24, 2010·Neuromuscular Disorders : NMD·Maaike van PuttenAnnemieke Aartsma-Rus
Aug 24, 2010·The Anatomical Record : Advances in Integrative Anatomy and Evolutionary Biology·Anderson Neri GuidoElaine Minatel
Jan 19, 2012·Journal of Neuroscience Research·Charlotte WellerJens Schmidt
Aug 14, 2012·Neurobiology of Disease·Hala S Alameddine
Feb 12, 2015·Journal of Muscle Research and Cell Motility·Jennifer Manning, Dervla O'Malley
Sep 23, 2008·The International Journal of Biochemistry & Cell Biology·Chiara MozzettaPier Lorenzo Puri
Jun 5, 2012·Molecular Genetics and Metabolism·A T PalermoR J Pomponio
Apr 17, 2012·International Journal of Rheumatology·Sture ForsgrenJames E Gaida
Feb 28, 2016·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·J ManningD O'Malley
May 24, 2016·PloS One·Margaret E Benny KlimekKanneboyina Nagaraju
Mar 16, 2017·Muscle & Nerve·Jennifer ManningDervla O'Malley
Aug 9, 2017·PloS One·Rafael Dias MâncioElaine Minatel
Dec 3, 2016·Journal of Neuromuscular Diseases·Hala S Alameddine, Jennifer E Morgan
Jun 27, 2019·Life Science Alliance·Milica MarinkovicGianni Cesareni

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here